Aim High - Adjuvant interferon in melanoma (high-risk), a United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) a randomised study of observation versus adjuvant low dose extended duration interferon alpha-2a in high risk resected malignant melanoma

BW Hancock, Keith Wheatley, G Harrison, M Gore

Research output: Contribution to conference (unpublished)Abstract

Original languageEnglish
Publication statusPublished - 1 Jan 2001
EventProc Am Soc Clin Concol -
Duration: 1 Jan 2001 → …


ConferenceProc Am Soc Clin Concol
Period1/01/01 → …

Cite this